Chief Executive Lynn Kirkpatrick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Rob Curran Shares of Ensysce Biosciences rallied after the developer of pain medication intended to be less prone to abuse received feedback from the Food.

San diegoUnited statesLynn kirkpatrickEnsysce biosciencesRob curranDrug administrationChief executive lynn kirkpatrickArticle normalHealthcare life sciencesSpecialized drugs medicationsPrescription drugsRegulation government policyFinancial performanceCorporate industrial newsContent typesFactiva filters